Meningitis Cases Associated with Injectable Steroids PDF Print E-mail

The Maryland Department of Health and Mental Hygiene (DHMH), in conjunction with other states, the Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (FDA), continues to investigate an association between spinal injections and the development of meningitis as part of a larger multi-state investigation. 

As this investigation continues, the Department will post updates off its home page,
www.dhmh.maryland.gov  under “Meningitis Cases Associated with Injectable Steroids.”

 

DHMH continues to urge people who have new or worsening symptoms, including symptoms of meningitis or stroke, following an injection of methylprednisolone acetate from one of the seven Maryland facilities that received the implicated NECC lots to contact their healthcare provider to determine if further evaluation is indicated. Symptoms of meningitis can include fever, headache, neck stiffness, photophobia, nausea, or vomiting. Stroke symptoms can include but are not limited to double vision, slurred speech, weakness on one side of the body, or difficulty walking.

 

Facilities that have received and pulled from use the affected product are:

Berlin Interventional Pain Management, Berlin, MD

Box Hill Surgery Center, Abingdon, MD

Greenspring Surgery Center, Baltimore, MD

Harford County Ambulatory Surgery Center, Edgewood, MD

Maryland Pain Specialists, Towson, MD

SurgCenter of Bel Air, Bel Air, MD

Zion Ambulatory Center, Baltimore, MD

Last Updated on Wednesday, 14 November 2012 10:27
 
 

Substance Abuse Help

 

Zika Information

 

Rabies Information


     

WCHD News

Medicaid, HealthChoice MCOs take steps to prevent opioid-related problems. Response follows treatment reimbursement boost in program’s renewed waiver.

Baltimore, MD (February 8, 2017) – In keeping with the Hogan administration’s leadership in fighting the opioid crisis in Maryland, the Department of Health and Mental Hygiene is announcing policies reforming the opioid-prescribing process in the Medicaid program, to seek to block the prescription pathway to substance use disorders.
Read more...
 
Maryland urges testing on National Black HIV/AIDS Awareness Day. State utilizing 5-year plan for prevention, care services; builds on collaborations.
 
Baltimore, MD (February 6, 2017) – Tuesday is National Black HIV/AIDS Awareness Day (NBHAAD), and the Department of Health and Mental Hygiene’s Prevention and Health Promotion Administration is encouraging all Marylanders to support HIV education, prevention, testing and care.
Read more...
 
Md. health dept., ex-Raven Orr ‘team up’ for public service videos on opioids. Marylanders can find treatment resources at MdDestinationRecovery.org.
 
Baltimore, MD (February 6, 2017) – As part of the Hogan administration’s continued efforts to save lives and promote recovery amid the opioid crisis, the Department of Health and Mental Hygiene’s Behavioral Health Administration has released a series of public service announcements (PSAs) to be shown on TV and in movie theaters.
Read more...
 
 Lower Shore Health Insurance Assistance Program
Web Mastering by
 www.WheatleyComputers.com